Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

US Interior Secretary Doug Burgum Talks US Energy Production
14:53

Nobel Laureate & CUNY Economics Professor Paul Krugman Talks Powell Investigation
06:04

Burlington CEO Michael O'Sullivan Talks Growth, Consumer Sentiment
10:04